亚盛医药-B(06855)授出130.45万份受限制股份单位及73.66万份购股权

Core Viewpoint - As of the announcement date, the company has granted a total of 1,304,500 restricted stock units to 146 selected individuals under the 2022 Restricted Stock Unit Plan, which corresponds to 1,304,500 shares [1] Group 1 - The company has also granted a total of 736,600 stock options to 34 grantees under the post-IPO stock option plan, which can be exercised to subscribe for a total of 736,600 ordinary shares of the company, pending acceptance by the option grantees [1]